#strong against COVID-19 - SKW Schwarz participates in Biolegis research on limitations of liability for vaccines in the EU

18.06.2020

SKW Schwarz is the only German law firm to be part of the Biolegis network, a pan-European network of independent law firms with in-depth expertise in life sciences.

In this capacity, SKW Schwarz is currently participating in a major Biolegis initiative to assess national facilitations in the respective approval procedures for COVID-19 vaccines.

The initiative focuses on regulatory issues relating to drug approval and possible modifications of existing statutory provisions with respect to the fight against COVID-19. Since a draft bill is not yet available, the initiative aims to offer international clients an overview of currently existing regulatory hurdles.